Ada Blidner

Ada Blidner is a prominent Argentine researcher affiliated with Conicet, known for her groundbreaking work in cancer immunology. As the lead author of a recent paper published in the prestigious journal Immunity, she has made significant strides in understanding how the protein Galectin-1 influences immune cells to support tumor growth. Her research focuses on the mechanisms by which myeloid-derived suppressor cells (MDSCs) are reprogrammed by Galectin-1 in the tumor microenvironment, contributing to immunosuppression and angiogenesis in cancer. Through her efforts, Blidner is at the forefront of developing new therapeutic strategies aimed at reversing these processes to improve cancer treatment outcomes.